Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
06/10/2010 | US20100143242 Delivery system for therapy comprising hollow seeds, and the method of use thereof |
06/10/2010 | US20100143241 Method and apparatus for delivery of agents across the blood brain barrier |
06/10/2010 | US20100140483 Radioimaging applications of and novel formulations of teboroxime |
06/10/2010 | CA2745958A1 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
06/10/2010 | CA2745955A1 Technetium- and rhenium- bis (heteroaryl) complexes and methods of use thereof for inhibiting psma |
06/10/2010 | CA2745923A1 Sparc binding scfvs |
06/10/2010 | CA2745918A1 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof |
06/10/2010 | CA2745899A1 Albumin binding peptide-mediated disease targeting |
06/10/2010 | CA2745495A1 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals |
06/09/2010 | EP2193115A1 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method |
06/09/2010 | EP2192928A2 Perfluoro-aryliodonium salts in nucleophilic aromatic 18f-fluorination |
06/09/2010 | CN101723850A Novel 18F labeled aromatic amino acids, preparation method and application thereof in tumor imaging |
06/09/2010 | CN101723849A Novel 18F labeled amino acid derivatives, preparation method and application thereof in tumor imaging |
06/09/2010 | CN101723848A Novel 18F labeled m-nitro benzoyl amino acids, preparation method and application thereof in tumor imaging |
06/09/2010 | CN101723847A Novel 18F labeled p-nitro benzoyl amino acid compound and preparation method and application thereof |
06/09/2010 | CN101723846A Novel 18F labeled p-nitro benzoyl amino acid derivatives, preparation method and application thereof in tumor imaging |
06/09/2010 | CN101721720A Nitroimidazole-amino acid compound nuclide hypoxic contrast agent and precursor thereof |
06/08/2010 | US7734331 Systems, methods and apparatus for preparation, delivery and monitoring of radioisotopes in positron emission tomography |
06/08/2010 | US7732159 Using plasminogin activator concentration as indicator of tumor progress and antitumor drug efficacy |
06/08/2010 | US7731995 Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal |
06/08/2010 | US7731979 Protective antigen having fluorinated histidine residues |
06/08/2010 | US7731936 metabolically stable metal complexes that are suitable for conjugation with biomolecules and radiology |
06/08/2010 | CA2458946C Composite staple for completing an anastomosis |
06/08/2010 | CA2389300C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
06/03/2010 | WO2010060217A1 Antibody-targeted carrier for contrast agents |
06/03/2010 | WO2010013139A3 Radionuclide-labeled erlotinib |
06/03/2010 | US20100137365 Long chain N-alkyl compounds and oxa-derivatives thereof |
06/03/2010 | US20100136626 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
06/03/2010 | US20100135906 In vivo imaging of sulfotransferases |
06/03/2010 | US20100135905 Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides |
06/03/2010 | US20100135904 Compositions and methods for the inhibition of cripto / grp78 complex formation and signaling |
06/03/2010 | US20100135903 Use of a dna damaging agent and a ligand for the treatment of cancer |
06/03/2010 | US20100135902 Papillomavirus pseudoviruses for detection and therapy of tumors |
06/03/2010 | US20100135901 Combination therapy |
06/03/2010 | US20100135900 Cd37 immunotherapeutic combination therapies and uses thereof |
06/03/2010 | CA2744344A1 Antibody-targeted carrier for contrast agents |
06/02/2010 | EP2190990A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
06/02/2010 | EP2190880A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
06/02/2010 | EP2190484A2 Improved radiopharmaceutical composition |
06/02/2010 | EP1438299B1 Bifunctional chelating agent for actinium |
06/02/2010 | CN101716353A Folic acid composite used for imageology diagnosis of tumor and lymphatic metastasis tumor |
06/01/2010 | US7728104 Process for preparing glycopeptide phosphonate derivatives |
06/01/2010 | US7727957 Treatment and delay of outset of Parkinson's disease |
06/01/2010 | US7727525 Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics |
06/01/2010 | US7727512 Nanoparticle emulsion in perfluorohydrocarbon solvent; chelating agents coupled, optionally through a spacer, to phosphoglyceride; magnetic resonance imaging; excretion of toxic paramagnetic ion |
06/01/2010 | US7727511 Agents for imaging soluble a-beta |
06/01/2010 | CA2440680C Steroids as agonists for fxr |
06/01/2010 | CA2370666C A tenascin-c isoform as a marker for neoplasias |
06/01/2010 | CA2256592C Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent |
06/01/2010 | CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
05/27/2010 | WO2010060104A2 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration |
05/27/2010 | WO2010059905A2 Imaging ligands |
05/27/2010 | WO2010058361A2 Method for the production of scaffolds for tissue engineering, comprising the use of an anchoring unit, and scaffold produced therewith |
05/27/2010 | US20100129290 Smart contrast agent and detection method for detecting transition metal ions |
05/27/2010 | US20100129289 Compositions and methods for the detection of vulnerable plaque |
05/27/2010 | US20100129288 Gliomedin, Fragments Thereof and Methods of Using Same |
05/26/2010 | EP2187803A1 Multimodality agents for tumor imaging and therapy |
05/26/2010 | EP1867634B1 Ligand for vesicular acetylcholine transporter |
05/26/2010 | EP1718737B1 Cancerous disease modifying antibodies |
05/26/2010 | EP1272665B1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
05/26/2010 | CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
05/26/2010 | CN1829735B Imaging agents |
05/26/2010 | CN1771058B Microwave method for preparing radiolabelled gallium complexes |
05/26/2010 | CN1665933B Immunoconjugates for the treatment of tumours |
05/26/2010 | CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
05/26/2010 | CN1638807B Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
05/26/2010 | CN101712721A T cell receptor fusions and conjugates and methods of use thereof |
05/25/2010 | US7723305 Abuse-resistant amphetamine prodrugs |
05/25/2010 | US7723049 Marker for inflammatory conditions |
05/25/2010 | US7722857 one or more kinds of immunostimulating substances carried separately by two or more kinds of microparticle immunostimulating substance carriers and comprising a combination of inorganic substance such as microparticle calcium phosphate and precipitates of soluble protein and mucopolysaccharide; antitumor |
05/25/2010 | US7722855 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell |
05/25/2010 | CA2361573C Biodegradable glass compositions and methods for radiation therapy |
05/20/2010 | WO2010009220A3 Radiolabelled trp m8 receptor ligands |
05/20/2010 | CA2743464A1 Therapeutic and diagnostic methods relating to cancer stem cells |
05/20/2010 | CA2743282A1 Simultaneous measurment of the in vivo metabolism of isoforms of a biomolecule |
05/19/2010 | EP2186508A2 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
05/19/2010 | EP2185933A2 Matriptase protein and uses thereof |
05/19/2010 | EP0907735B9 Modulators of tissue regeneration |
05/19/2010 | CN101709060A F-triazole ring-polyethylene glycol-metronidazole compound and preparation method thereof |
05/18/2010 | US7718777 MHC-peptide complex binding ligands |
05/18/2010 | US7718619 Abuse-resistant amphetamine prodrugs |
05/18/2010 | US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ |
05/18/2010 | US7718599 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases |
05/18/2010 | US7718161 Method for treating a motoneuron disorder |
05/18/2010 | US7718160 Radiolabeled compounds and liposomes and their method of making and using same |
05/14/2010 | WO2010052143A1 Radiolabelled inhibitors of the glycine 1 transporter |
05/14/2010 | CA2742515A1 Modulators of cxcr7 |
05/13/2010 | US20100121184 Systems, methods and apparatus for preparation, delivery and monitoring of radioisotopes in positron emission tomography |
05/13/2010 | US20100120688 ErbB Interface Peptidomimetics And Methods Of Use Thereof |
05/13/2010 | US20100119448 Method for production of radiation diagnostic imaging agent |
05/13/2010 | US20100119447 Radiolabeled lymphatic staining agents and methods for making |
05/13/2010 | US20100119446 Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
05/13/2010 | US20100119445 Plexin d1 as a target for tumor diagnosis and therapy |
05/13/2010 | US20100119444 Tumor-Targeting Peptides and Uses Thereof |
05/13/2010 | US20100119443 Radiotherapeutic system and method performed by non-invasive and real-time tumor position tracking |
05/12/2010 | EP2183275A1 Igf-1r binding polypeptides and their use |
05/12/2010 | EP2183272A2 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment |
05/12/2010 | EP2182988A2 Radiopharmaceutical composition |
05/12/2010 | EP2182956A2 Salicylanilide modified peptides for use as oral therapeutics |
05/12/2010 | CN1867363B Mechanism-based targeted pancreatic beta cell imaging and therapy |